Biotage AB (publ) appoints new CFO
Annette Colin has been appointed as new CFO and member of Biotage AB (publ) Group Management, based out of the Group Headquarters in Uppsala, Sweden.
Annette brings more than 30 years of experience from different functions within finance and management, mostly in the life science industry. Annette has a long career in executive management positions, for the most part as CFO, and she has been a member of the management team in several publicly listed companies. Most recently Annette has been running her own consultancy business within finance, business development, management and transactions. Examples of previous job experiences are with Annexin Pharmaceuticals AB (publ), Observe Medical International (publ), Stille AB (publ), Lindab International AB (publ), Perbio Science AB (publ) and EY.
“I am very happy to welcome Annette as new CFO for Biotage. Annette has a long experience in leading financial and strategic roles, which makes me convinced that she very soon will be able to contribute to Biotage’s continued development.”, says Tomas Blomquist, CEO and President of Biotage.“
Annette assumes her new position on April 1, 2020. Lars Bäckman will leave his role as Interim CFO simultaneously and return to his role as CLO.
Tomas Blomquist, CEO
Tel: 0705 23 01 63, firstname.lastname@example.org
Lars Bäckman, CLO
Tel: 0707 72 74 49, email@example.com
This information was submitted for publication, through the agency of the contact persons set out above, at 14.30 CET on March 17, 2020
Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, contract research and contract manufacturing companies, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 460 employees and had sales of 1 101 MSEK in 2019. Biotage is listed on NASDAQ Stockholm. Website: www.biotage.com